Patient journey
Journey maps grounded in primary research with patients and caregivers, not workshop hunches.
Shortlist it, send it over — we come back with the shape we'd actually recommend.
What patient journey actually is.
Journey maps grounded in primary research with patients and caregivers, what they do, what they feel, where the caregiver burden actually sits, where the asset can credibly help, rather than workshop hunches written up in a deck.
Built for medical, commercial and access teams that need lived experience in the room when product, evidence and engagement decisions are being made, not represented by proxy a quarter after the fact.
- Journey maps from primary patient and caregiver research
- Touchpoint, drop-off and switch-point analysis
- Caregiver burden register
- Implications by function (medical, access, commercial)
- Working session and read-out with the cross-functional team
Add the pieces you'd want and we'll build a shortlist you can review, reorder and send over. No pricing wall, no commitment — we come back with what we'd actually recommend, including anything you don't need.
Approach, modules, delivery.
Move through the tabs to see how the work runs, what it's made of and what lands at the end.
Inputs
- Primary research with patients and carers (qualitative + quantitative)
- HCP interviews along the journey, by specialty and care setting
- Claims-derived treatment-pathway evidence where consented and available
- Real-world EHR pathway data and registry-level treatment sequences
Method
Patient Journey Studio holds the pathway, the emotion curve, the drop-off graph and the intervention ledger in one workspace. Journeys are grounded in primary research and calibrated to claims and EHR pathways where the data exists. Stages, touchpoints and decision points are versioned per market and per subgroup; drop-offs are scored, interventions are sized and the live map writes into Advocacy Graph, Narrative Workbench, RWE Console and Burden Engine so the journey is operational, not decorative.
Assumptions
- Primary research access (patients, carers, HCPs) is feasible within scope.
- Claims or pathway data, where used, reasonably represent the population.
- Stages, touchpoints and decision points can be reconciled across markets to a single taxonomy.
Limitations
- Journeys vary across markets and subgroups, a single map is a useful average, not the truth.
- Some emotional touchpoints are inaccessible to claims data and need qualitative input.
- Pathway data lags real practice, refresh quarterly when registries and claims update.
Think this belongs in your scope?
Add it alongside anything else that fits, then send the shortlist over. We'll reply with the shape we'd recommend — sequence included, and the parts we think you can skip.
Build what comes next.
Whether you need growth, answers or capability, VISFO helps you move earlier and faster.